Trainees in the UAB-HudsonAlpha Genomic Medicine Training Program presented a seminar at HudsonAlpha on Wednesday, February 7. Nick Cochran, PhD, gave a talk titled “Whole Genome Sequencing for Families with Early-Onset Neurologic Diseases: A UAB-HudsonAlpha Collaboration,” and Nadiya Sosonkina, PhD, presented “Rare diseases: diverse approaches to improve diagnosis.”
Nicholas Cochran, PhD, received his PhD in neuroscience from the University of Alabama at Birmingham. He is a postdoctoral fellow in the lab of Richard Myers, PhD, at HudsonAlpha Institute for Biotechnology. In 2016, Cochran was selected as a trainee in the UAB-HudsonAlpha Genomic Medicine Training Program. His interest lies in mechanistic investigation of neurologic disease etiology, with an emphasis on neurodegenerative diseases.
Nadiya Sosonkina, PhD, graduated from the School of Pharmaceutical Science, Health Sciences, at the University of Hokkado in Hokkaido, Japan, in 2012. In the following year, she joined the Medical College of Wisconsin in Milwaukee, where she ultimately joined the Howard Jacob laboratory, focusing on genetics of rare diseases. Sosonkina joined HudsonAlpha Institute for Biotechnology in 2016 and was selected in 2017 as a trainee in the UAB-HudsonAlpha Genomic Medicine Training Program. Her research focuses on the utilization of novel sequencing technologies to improve the outcome for undiagnosed diseases. She has a particular interest in the genetics of autism spectrum disorder.